Literature DB >> 20979833

[MicroRNA differential expression profile in nephroblastoma cell line versus normal embryonic kidney cell line].

Jia-xiang Wang1, Qian Hu, Qiu-liang Liu, Yuan Wei.   

Abstract

OBJECTIVE: To explore the microRNA (miRNA) differential expression profile between nephroblastoma cell line G401 and normal embryonic kidney cell line CCC-HEK-1 so as to provide rationales for the role of miRNA in the pathogenesis of nephroblastoma.
METHODS: Three samples from G401 cell line and another 3 samples from CCC-HEK-1 cell line were chosen as the experimental group and the control group respectively. miRNA profiles in these samples were analyzed by microarray. The threshold value used to screen up and down-regulated miRNAs was fold change ≥ 2 or ≤ 50.0%. And real-time PCR was used to validate the reliability of microarray.
RESULTS: Seventy-one miRNAs were found up-regulated in the experimental group and 11 of them were more than 8 times versus control group. In addition, 59 miRNAs were found down-regulated and 11 of them were 12.5% versus control group. Overall, there were significant differences in the expression of miRNA between G401 and CCC-HEK-1 cell lines.
CONCLUSIONS: There is a differential expression of miRNA between G401 and CCC-HEK-1 cell lines. It may be related with occurrence and metastasis of nephroblastoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20979833

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  2 in total

1.  [Expression of miR-155-5p in Wilms tumor and its regulatory role in proliferation, migration and apoptosis of Wilms tumor cells in vitro].

Authors:  Xin Luo; Junjun Dong; Xingyue He; Lianju Shen; Chunlan Long; Feng Liu; Xing Liu; Tao Lin; Dawei He; Guanghui Wei
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-12-30

Review 2.  The roles of microRNAs in Wilms' tumors.

Authors:  Xin Yu; Zheng Li; Matthew T V Chan; William Ka Kei Wu
Journal:  Tumour Biol       Date:  2015-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.